iO Urology announces the addition of Steve Blum to its Board of Directors
August 15 2024 - 9:13AM
Business Wire
iO Urology is thrilled to announce the addition of Steve Blum to
our Board of Directors. Steve brings a wealth of experience and an
impressive track record of success in the urological medical device
industry. His appointment marks a significant milestone as we
continue to advance our mission of providing innovative solutions
for urological care.
Steve Blum joins iO Urology with a distinguished background,
including recent roles as Global President at both Coloplast and
American Medical Systems. Over his six-year tenure at Coloplast,
Blum was instrumental in leading the company’s Men’s Health,
Endosurgery, and Women’s Health Interventional Urology divisions.
Under his leadership Coloplast achieved remarkable global growth
and operational excellence.
Prior to his role at Coloplast, Blum served as Global President
and General Manager of the FPH Division at American Medical
Systems, where he oversaw operations in 75 countries. His
leadership was pivotal in positioning American Medical Systems as a
leader in the development and marketing of medical devices focused
on restoring pelvic health for both men and women.
Blum’s appointment to the iO Urology Board is a testament to his
strong strategic mindset, growth orientation, and commitment to
excellence. His proven track record of driving innovation, coupled
with his authentic leadership style and fiscal discipline, aligns
perfectly with iO Urology’s values and vision.
As we welcome Steve Blum to our Board of Directors, we are
excited about the future and the expertise he will bring to our
team. His extensive experience and leadership will undoubtedly
contribute to our ongoing success and our commitment to delivering
cutting-edge urological solutions.
About iO Urology
iO Urology is a pioneering leader in the urological care field,
dedicated to advancing patient outcomes by offering a convenient,
accessible solution for managing urological conditions in the home.
Using embedded cellular connectivity, the CarePath® device provides
reliable, accurate data that improves the diagnosis and management
of lower urinary tract symptoms. Our mission is to develop and
deliver cutting-edge solutions that address the complexities of
urological conditions, enhancing both patient quality of life and
clinical effectiveness. iO Urology strives to set new standards in
the industry by empowering both patients and healthcare
professionals with the knowledge they need to make informed
decisions.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240814833593/en/
Britton Garrett, Chief Executive Officer
brittongarrett@iourology.com